A cohort description and comparison of four European national diabetes registries for the REDDIE project

Documenti analoghi

• Glucagon‐like‐peptide‐1 receptor agonists versus dipeptidyl peptidase‐4 inhibitors and cardiovascular outcomes in diabetes in relation to achieved glycemic control. A Danish nationwide study
  di: Bochra Zareini, et al.
  Pubblicazione: (2024)
• Sustained glucagon‐like peptide‐1 receptor agonist treatment improves glycemic control and reduces all‐cause mortality compared to dipeptidyl peptidase‐4 inhibitors: A real‐world target trial emulation in type 2 diabetes
  di: Kathrine Kold Sørensen, et al.
  Pubblicazione: (2026)
• Poor socioeconomic outcomes: Completion of the final examination after lower secondary education mitigates risks associated with gestational age
  di: Rikke Wiingreen, et al.
  Pubblicazione: (2024)
• Effectiveness of add‐on therapy with SGLT2 inhibitors or GLP ‐1 receptor agonists in adults with type 1 diabetes: A prospective DPV registry study
  di: Christina Baechle, et al.
  Pubblicazione: (2024)
• Prescription distribution and inequities in diabetes care: A comparative analysis of continuous glucose monitoring access by diabetes status, ethnicity and socio‐economic factors in England
  di: Samuel Seidu, et al.
  Pubblicazione: (2025)